Suppr超能文献

脑膜炎患儿中头孢曲松的动力学及脑脊液穿透情况

Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.

作者信息

Nahata M C, Durrell D E, Barson W J

出版信息

Chemotherapy. 1986;32(2):89-94. doi: 10.1159/000238395.

Abstract

20 patients (0.4-5.6 years old) receiving ceftriaxone for the treatment of bacterial meningitis were studied. Simultaneous serum and cerebrospinal fluid concentrations of ceftriaxone were determined by HPLC in 15 patients at 11.4-12.8 h after an intravenous loading dose of 75 mg/kg. Serum and cerebrospinal fluid concentrations ranged from 20.5 to 44.9 (31.3 +/- 7.8) and from 1.1 to 8.0 (3.7 +/- 1.8) micrograms/ml, respectively. Cerebrospinal fluid concentrations ranged from 3 to 25% (12 +/- 6%) of the simultaneous serum concentrations. In 6 patients, serum and cerebrospinal fluid concentrations were determined after maintenance doses of 50 mg/kg/12 h. Serum and cerebrospinal fluid concentrations ranged from 120 to 144 and 2.3-4.9 micrograms/ml at 1.8-5.5 h after the first maintenance dose in 2 patients; 74-139 and 5.7-7.9 micrograms/ml at 1.3-5.8 h after the second dose in 3 patients and was 101 and 4.1 micrograms/ml at 4 h after the 3rd dose in 1 patient. Multiple blood samples were collected after the loading dose in 5 patients and after 9-10 days of maintenance doses in 3 patients. Steady-state peak and trough serum concentrations ranged from 295 to 440 and 32.6-44.8 micrograms/ml, respectively. After the loading and maintenance dose at steady-state, total body clearance averaged 1.17 and 0.64 ml/min (p = 0.01); apparent volume of distribution averaged 0.37 and 0.26 l/kg (p greater than 0.05); and elimination half-life averaged 3.7 and 4.6 h (p = 0.01), respectively. These results suggest that (1) adequate cerebrospinal fluid concentrations of ceftriaxone can be achieved in patients with meningitis with the dosage regimen studied.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对20例(年龄0.4 - 5.6岁)接受头孢曲松治疗细菌性脑膜炎的患者进行了研究。15例患者在静脉注射75mg/kg负荷剂量后11.4 - 12.8小时,通过高效液相色谱法测定了头孢曲松的血清和脑脊液同步浓度。血清和脑脊液浓度分别为20.5至44.9(31.3±7.8)和1.1至8.0(3.7±1.8)μg/ml。脑脊液浓度为同步血清浓度的3%至25%(12±6%)。6例患者在50mg/kg/12h维持剂量后测定了血清和脑脊液浓度。2例患者在首次维持剂量后1.8 - 5.5小时,血清和脑脊液浓度分别为120至144和2.3 - 4.9μg/ml;3例患者在第二次剂量后1.3 - 5.8小时,血清和脑脊液浓度分别为74 - 139和5.7 - 7.9μg/ml;1例患者在第三次剂量后4小时,血清和脑脊液浓度分别为101和4.1μg/ml。5例患者在负荷剂量后以及3例患者在维持剂量9 - 10天后采集了多个血样。稳态峰浓度和谷浓度血清浓度分别为295至440和32.6 - 44.8μg/ml。在负荷和稳态维持剂量后,总体清除率平均为1.17和0.64ml/min(p = 0.01);表观分布容积平均为0.37和0.26l/kg(p>0.05);消除半衰期平均为3.7和4.6小时(p = 0.01)。这些结果表明:(1)在所研究的给药方案下,脑膜炎患者可达到足够的头孢曲松脑脊液浓度。(摘要截断于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验